Intellia Therapeutics - Global Health Economics and Outcomes Research Postdoctoral Research Fellow

About the Opportunity Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program’s success is preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry. Fellows have the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Intellia Therapeutics is offering a two-year Health economics and outcomes research (HEOR) fellowship, based in Cambridge, MA. About Intellia Intellia Therapeutics is a Cambridge-based biotechnology company focused on developing clustered regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies to transform lives of people with severe diseases. In fact, Intellia’s co-founder Jennifer Doudna along with Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. At Intellia, we are humbled to contribute to what we believe to be medical history. As a leader in this field, our responsibility and commitment to patients is critical in our pursuit of developing novel, potentially curative therapeutics utilizing CRISPR-based technologies. More specifically, we are employing a modular gene editing platform to create diverse in vivo and ex vivo therapeutics, spanning a range of disease indications. Guided by this full-spectrum approach, we are committed to making CRISPR-based medicines a reality for people living with genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases. Intellia HEOR Fellowship Program Overview Northeastern University Pharmaceutical Industry Fellowships Program is a 2-year experiential program designed to advance lifelong learning and the education and training of PharmD/MPH/PhD graduates. A key element of the program’s success is preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry. Fellows have the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Intellia Therapeutics is offering a 2-year Global HEOR and Evidence Strategy fellowship, based in Cambridge, MA. What Sets the Intellia Fellowship Apart? During the program, Fellows will work collaboratively and cross-functionally in Intellia’s HEOR and Evidence Strategy team, gaining exposure to our high-energy, fast-paced, and supportive culture. The HEOR and Evidence Strategy team sits within the Market Access and Patient Services team in the Commercial Organization. At Intellia, a technical and scientific expertise background is highly valued. The Fellowship offers a uniquely structured experience, beginning with a foundational year working with the Director, HEOR and Evidence Strategy supporting the HEOR strategy for Intellia’s novel, gene-editing therapies. This foundational year provides the Fellow with a strong understanding of strategic development of value and evidence generation strategy to support clinical development and commercial brand plans. In the second year, the Fellow will have an option to participate in 1-3 projects/activities within the broader Market Access and Patient Services team. These optional activities will aim to give the Fellow exposure to key strategic or execution activities that fall within Field HEOR and Market Access Strategy. This will allow the Fellow to gain blended exposure across Intellia’s dynamic business functions and build a versatile skill set for a future in biotech. Responsibilities DEVELOP in-depth knowledge of Intellia’s CRISPR gene editing technology, disease and treatment landscape of relevant therapeutic areas—to support strategic evidence generation to support the product value proposition LEARN to execute global/US HEOR studies which span across the key scientific pillars including; Patient-focused drug development including patient-reported outcomes as key measures in clinical trials Real-world evidence generation and analysis to identify unmet needs and inform comparative effectiveness, global epidemiology to support regulatory interactions and stakeholder disease education & awareness Evidence synthesis with literature reviews and indirect/mixed treatment comparisons Health economic models (cost effectiveness analysis and budget impact analysis), and target patient population tools (US intended use and ex-US target patient population) Global HEOR activities In support of US launch – pre-approval information exchange (PIE) tools and post-approval value tools Strategy and planning related to various country-specific health authority (HTA) interactions and reimbursement dossier development SUPPORT or LEAD development of HEOR publications for scientific conferences and peer-reviewed journals; ensure the publication plans are up-to-date for HEOR studies BE an active contributor by helping to executing HEOR tactics including management of external vendors helping with study execution SUPPORT development of presentations for internal team meetings to drive cross-functional collaboration and discussion to improve the quality of the work MANAGE HEOR external facing materials development and approval via Veeva PromoMats Optional project experience with other functions of Market Access and Patient Services in year 2: Field HEOR: Partner with field teams to translate HEOR evidence into customer-facing value narratives and support scientific exchange with payers/providers, in collaboration with Payer Account Management team. Market Access Strategy: Contribute to cross-functional market access planning by assessing evidence gaps, evaluating payer landscape insights, and helping shape value propositions across key stakeholder segments. PARTICIPATE in future fellowship recruitment activities and interviews Qualifications Doctor of Pharmacy (PharmD) degree from an ACPE-accredited institution Eligible for pharmacist licensure in the State of Massachusetts Elective study or experience related to Epidemiology/Outcomes Research/Health Economics, Statistics/Biostatistics, Real-world Evidence Research, etc. is a plus Advanced degree (PhD/MS/MPH) in related fields like health economics and outcomes research, epidemiology, or public health is preferred Excellent oral, written communication, medical writing skills Strong scientific acumen, ability to simplify complex scientific data, and an interest in gene-editing and CRISPR Strong time management and leadership abilities Ability to work independently and take initiative on a variety of projects at both the industry site and Northeastern Capability for hybrid or in-person work arrangement, with an expectation to be on-site at Intellia approximately 4 times per month, subject to team and project needs Ability to travel to scientific conferences in the US or internationally per business needs Additional Information Position Type Research Compensation Grade/Pay Type: 108S Expected Hiring Range: $60,315.00 - $85,192.50 With the pay range(s) shown above, the starting salary will depend on several factors, which may include your education, experience, location, knowledge and expertise, and skills as well as a pay comparison to similarly-situated employees already in the role. Salary ranges are reviewed regularly and are subject to change. Northeastern University considers factors such as candidate work experience, education and skills when extending an offer. Northeastern has a comprehensive benefits package for benefit eligible employees. This includes medical, vision, dental, paid time off, tuition assistance, wellness & life, retirement- as well as commuting & transportation. All qualified applicants are encouraged to apply and will receive consideration for employment without regard to race, religion, color, national origin, age, sex, sexual orientation, disability status, or any other characteristic protected by applicable law. Northeastern University will not provide H-1B, TN, O-1, E-3, or any other type of employment visa sponsorship for the successful applicant to this position, now or in the future. STEM OPT is not compatible for this position. The successful applicant must be able to maintain valid work authorization in the United States throughout the entire appointment without Northeastern University's sponsorship for a visa. The successful applicant must be able to maintain valid work authorization in the United States throughout the entire appointment without Northeastern University's sponsorship for a visa. Founded in 1898, Northeastern is a global research university and the recognized leader in experiential lifelong learning. Our approach of integrating real-world experience with education, research, and innovation empowers our students, faculty, alumni, and partners to create worldwide impact. Our global university system provides our community and academic, government, and industry partners with unique opportunities to think locally and act globally. The system—including 14 campuses across the U.S., U.K., and Canada, 300,000-plus alumni, and 3,000 partners worldwide—serves as a platform for scaling ideas, talent, and solutions. The university’s residential campuses for undergraduate and graduate degrees are located in Boston, London, and Oakland, California. Our research and graduate campuses are in the Massachusetts communities of Burlington and Nahant; Arlington, Virginia; Charlotte, North Carolina; Miami; Portland, Maine; Seattle; Silicon Valley, California; Toronto; and Vancouver. Northeastern’s personalized, experiential undergraduate and graduate programs lead to degrees through the doctorate in 10 colleges and schools across our campuses. Learning emphasizes the intersection of data, technology, and human literacies, uniquely preparing graduates for careers of the future and lives of fulfillment and accomplishment. Our research enterprise, with an R1 Carnegie classification, is solutions oriented and spans the world. Our faculty scholars and students work in teams that cross not just disciplines, but also sectors—aligned around solving today’s highly interconnected global challenges and focused on transformative impact for humankind. #J-18808-Ljbffr NU USA Northeastern University